HIGHLIGHTS
- who: Colin R., Dormuth and Therapeutics, Initiative from the , University of British Columbia, Vancouver, Canada, Department of Anesthesiology, Pharmacology and, University of British have published the Article: Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis - A Population-Based Cohort Study, in the Journal: PLOS ONE | www.plosone.org of August/20,/2014
- what: This theoretical perspective on persistence seems to hold for TNF antagonist drugs - the main reasons for discontinuing or switching these drugs in RA were decreased benefit (36-67% of the discontinuations) or perceived harm (30-58%) . The aim of this study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.